Electrophysiology is defined as the branch of science that deals with the study of electrical pathway associated with heart nervous system. Electrophysiology devices are designed to measure electric current or voltage change on a wide range of scale from single ion channel protein to organs such as heart. The electrophysiology procedure is used to analyze heartโs electrical system and to manage abnormal heart rhythms.
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
- ABBOTT LABORATORIES
- Biotronik SE & Co. KG
- BOSTON SCIENTIFIC CORPORATION
- CardioFocus, Inc.
- GE Healthcare
- Koninklijke Philips N.V.
- Johnson & Johnson Services, Inc.
- Medtronic plc. (Zephyr Technology Corporation)
- MICROPORT SCIENTIFIC CORPORATION
- Siemens Healthineers AG
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/452
Factors that drive growth of the global electrophysiology market include rise in demand for catheter ablation procedure, advancements in technology in the medical device sector, and surge in demand for early diagnosis. In addition, rise in prevalence of cardiac arrhythmia such as atrial fibrillation, atrial flutter, and ventricular arrhythmia contributes toward growth of the global market. According to the International Journal of Stroke, in 2020, it was analyzed that atrial fibrillation is the most frequent cardiac arrhythmia. Ablation is the most common procedure for treatment of atrial fibrillation, which is expected to increase the need for electrophysiology devices, thus driving growth of the market.
Furthermore, market players are focused on manufacturing of different electrophysiology devices such as ablation catheter, diagnostic catheter, and 3D mapping system. For instance, in January 2022, Abbott laboratory, a pharmaceutical company, announced clearance from the Food and Drug Administrative (FDA) for its EnSite X EP system with EnSite omnipolar technology (OT), in the U.S. and Europe. It is a cardiac mapping platform, designed to help doctors for treatment of cardiac arrhythmia. Moreover, increase in number of geriatric populations and rise in prevalence of chronic conditions such as diabetics and hypertension, who are more prone to atrial fibrillation escalate the electrophysiology (EP) market growth. According to the Journal of J Arrhythm, in August 2021, it was reported that around 70% of population between the ages of 65 and 85 years were diagnosed with atrial fibrillation.
๐๐ผ๐๐ถ๐ฑ-๐ญ๐ต ๐ฆ๐ฐ๐ฒ๐ป๐ฎ๐ฟ๐ถ๐ผ:
The COVID-19 outbreak is anticipated to have a negative impact on growth of the global electrophysiology market. Implementation of lockdown has delayed the ablation procedure; thereby, having a minimal negative impact on the market. The COVID-19 pandemic has stressed healthcare systems in the world and increased the need for advanced hospitals. Many hospitals across the globe, including cardiac centers were restructured to increase hospital capacity for patients diagnosed with COVID-19. This leads to cancellation of many non-essential surgical procedures and the quality of care toward patients other than COVID-19 decreases. This has significantly contributed to decline of the global market.
๐
๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/452
North America garnered a major share of the EP market in 2020, and is expected to continue to dominate during the forecast period, owing to rise in prevalence of cardiac arrhythmia, increase in number of approvals for electrophysiology, and strong presence of key players. However, Asia-Pacific is expected to register highest CAGR of 15.1% from 2021 to 2030, owing to increase in prevalence of atrial fibrillation, advancements in technology in the field of electrophysiology market, and initiatives taken by governments to enhance healthcare infrastructure.
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com